guanfacine has been researched along with Dizzyness in 1 studies
Guanfacine: A centrally acting antihypertensive agent with specificity towards ADRENERGIC ALPHA-2 RECEPTORS.
| Excerpt | Relevance | Reference |
|---|---|---|
| " This report documents the time course and predictors of symptom efficacy and sedation-related adverse events (AEs) that emerge during GXR treatment throughout 3 randomized, placebo-controlled, double-blind trials of the drug." | 1.36 | Effects of extended-release guanfacine on ADHD symptoms and sedation-related adverse events in children with ADHD. ( Faraone, SV; Glatt, SJ, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Faraone, SV | 1 |
| Glatt, SJ | 1 |
1 other study available for guanfacine and Dizzyness
| Article | Year |
|---|---|
Effects of extended-release guanfacine on ADHD symptoms and sedation-related adverse events in children with ADHD.
Topics: Adolescent; Adrenergic alpha-Agonists; Attention Deficit Disorder with Hyperactivity; Child; Delayed | 2010 |